GlassScriptPhysician profile
Richard A Bernard
NPI 1063713170
$3,636.67
in general payments reported to CMS, 2019-2025
21 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $741 · 2023: $1,115 · 2024: $652 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $926.72 | 2021-2024 | Xarelto, Acclaim |
| Sanofi-Aventis U.S. LLC | $471.25 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $404.18 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.31 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.79 | 2021-2025 | Lifevest |
| Cvrx, INC. | $197.83 | 2023-2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $186.90 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $155.65 | 2021-2024 | Farxiga |
| Abbott Laboratories | $136.55 | 2023-2025 | Jot Dx, Aveir, Amplatzer Amulet |
| Pfizer INC. | $133.38 | 2022-2025 | |
| Boston Scientific Corporation | $107.44 | 2022-2025 | General - Ep |
| Novartis Pharmaceuticals Corporation | $63.89 | 2021-2023 | |
| Biotronik INC. | $57.94 | 2025 | Biomonitor, Rivacor 7 Dr-T |
| Bayer Healthcare Pharmaceuticals INC. | $55.48 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $38.61 | 2024 | Assure Wcd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $38.48 | 2024-2025 | Optimizer |
| Medtronic, INC. | $25.30 | 2025 | Azure Xt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $19.51 | 2021 | |
| Novo Nordisk INC | $19.17 | 2023 | Wegovy |
| Medicomp INC | $18.47 | 2024 | Telepatch Cardiac Monitor |
| Altathera Pharmaceuticals LLC | $12.82 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.